{"id":1055,"date":"2026-06-18T10:50:44","date_gmt":"2026-06-18T08:50:44","guid":{"rendered":"http:\/\/134.122.68.66\/investor-relations\/financial-calendar\/"},"modified":"2026-11-16T14:13:00","modified_gmt":"2026-11-16T13:13:00","slug":"financial-calendar","status":"publish","type":"page","link":"https:\/\/www.cy4gate.com\/en\/investor-relations\/financial-calendar\/","title":{"rendered":"Financial Calendar"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<\/p>\n<h3>Year 2027<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 11, 2027<\/strong><br \/>\nBoard of Directors\u2019 Meeting to approve the draft annual financial statements and the Consolidated Financial Statements as of 31st December 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 12, 2027<\/strong><br \/>\nAnalysts and Investors Conference Call on the FY 2026 financial results<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 28, 2027 (single call)<\/strong><br \/>\nShareholders\u2019 Meeting to approve the draft annual financial statements as of December 31, 2026, and present the consolidated financial statements as of 31st December 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 13, 2027<\/strong><br \/>\nBoard of Directors\u2019 Meeting to approve the additional consolidated financial information as of 31st March 2027<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 14, 2027<\/strong><br \/>\nAnalysts and Investors Conference Call on the additional consolidated financial Information as of 31st March 2027<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 9, 2027<\/strong><br \/>\nBoard of Directors\u2019 Meeting to approve the consolidated half-year financial report as of 30th June 2027<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 10, 2027<\/strong><br \/>\nAnalysts and Investors Conference Call on the consolidated half-year financial report as of 30th June 2027<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 11, 2027<\/strong><br \/>\nBoard of Directors\u2019 Meeting to approve the additional consolidated financial information as of 30th September 2027<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 12, 2027<\/strong><br \/>\nAnalysts and Investors Conference Call on the additional consolidated financial information as of 30th September 2027<\/li>\n<\/ul>\n<h3><\/h3>\n<p>&nbsp;<\/p>\n<h3>Year 2026<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 12, 2026<\/strong><br \/>\nBoard of Directors meeting to approve the draft annual financial statements and consolidated financial statements as of December 31, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 13, 2026<\/strong><br \/>\nAnalysts and Investors Conference Call for Fiscal Year 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 28, 2026<\/strong> <strong>(Single meeting)<\/strong><br \/>\nShareholders\u2019 Meeting to approve the financial statements as of December 31, 2025, and to present the consolidated financial statements as of December 31, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 14, 2026<\/strong><br \/>\nBoard of Directors meeting to approve the supplemental consolidated financial information as of March 31, 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 15, 2026<\/strong><br \/>\nAnalysts and Investors Conference Call: Additional Consolidated Financial Information as of March 31, 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 10, 2026<\/strong><br \/>\nBoard of Directors meeting to approve the consolidated semiannual financial report as of June 30, 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 11, 2026<\/strong><br \/>\nAnalyst and Investor Conference Call on the Consolidated Half-Year Financial Report as of June 30, 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 12, 2026<\/strong><br \/>\nBoard of Directors meeting to approve the additional consolidated financial information as of September 30, 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 13, 2026<\/strong><br \/>\nAnalyst and Investor Conference Call: Additional Consolidated Financial Information as of September 30, 2026<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3>Year 2025<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 12, 2025<\/strong><br \/>\nBoard of Directors meeting to approve the draft annual financial statements and consolidated financial statements as of December 31, 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 12, 2025<\/strong><br \/>\nAnalysts and Investors Conference Call for Fiscal Year 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 28, 2025<\/strong> <strong>(single meeting)<\/strong><br \/>\nShareholders\u2019 Meeting to approve the financial statements as of December 31, 2024, and to present the consolidated financial statements as of December 31, 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 14, 2025<\/strong><br \/>\nBoard of Directors meeting to approve the supplemental consolidated financial information as of March 31, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 15, 2025<\/strong><br \/>\nAnalyst and Investor Conference Call: Additional Consolidated Financial Information as of March 31, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 11, 2025<\/strong><br \/>\nBoard of Directors meeting to approve the consolidated semiannual financial report as of June 30, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 12, 2025<\/strong><br \/>\nAnalyst and Investor Conference Call on the Consolidated Half-Year Financial Report as of June 30, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 13, 2025<\/strong><br \/>\nBoard of Directors meeting to approve the additional consolidated financial information as of September 30, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 14, 2025<\/strong><br \/>\nAnalyst and Investor Conference Call: Additional Consolidated Financial Information as of September 30, 2025<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3>Year 2024<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>February 2, 2024<\/strong><br \/>\nBoard of Directors meeting to approve the preliminary results as of December 31, 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 14, 2024<\/strong><br \/>\nBoard of Directors meeting to approve the draft annual financial statements and consolidated financial statements as of December 31, 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 15, 2024<\/strong><br \/>\nFY 2023 Analyst and Investor Conference Call<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 22, 2024 (1st meeting)<\/strong><br \/>\nShareholders\u2019 Meeting for the approval of the financial statements as at 31 December 2023 and presentation of the consolidated financial statements as at 31 December 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 22, 2024<\/strong> <strong>(2nd meeting)<\/strong><br \/>\nShareholders\u2019 Meeting for the approval of the financial statements for the year ended 31 December 2023 and presentation of the consolidated financial statements as at 31 December 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 14, 2024<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the additional consolidated financial information as at 31 March 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>May 15, 2024<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 Additional Consolidated Financial Information as at 31 March 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 12, 2024<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the consolidated half-year financial report as at 30 June 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 13, 2024<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 Consolidated Half-Year Financial Report as at 30 June 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 12, 2024<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the additional consolidated financial information as at 30 September 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 13, 2024<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 Additional Consolidated Financial Information as at 30 September 2024<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3>Year 2023<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 23, 2023<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the draft financial statements for the year ended 31 December 2022<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 24, 2023<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 FY 2022<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 27, 2023 (1st meeting)<\/strong><br \/>\nOrdinary Shareholders\u2019 Meeting for the approval of the financial statements for the year ended 31 December 2022<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 28, 2023<\/strong> <strong>(2nd meeting)<\/strong><br \/>\nOrdinary Shareholders\u2019 Meeting for the approval of the financial statements for the year ended 31 December 2022<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 13, 2023<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the Half-Year Financial Report as at 30 June 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 14, 2023<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 H1 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 14, 2023<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the Interim Management Report as at 30 September 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>November 15, 2023<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 Q3 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3>Year 2022<\/h3>\n<ul>\n<li><strong>March 17, 2022<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the draft financial statements for the year ended 31 December 2021<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 18, 2022<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 FY 2021<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 14, 2022<\/strong> <strong>(1st meeting)<\/strong><br \/>\nOrdinary Shareholders\u2019 Meeting for the approval of the financial statements for the year ended 31 December 2021<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>April 19, 2022<\/strong> <strong>(2nd meeting)<\/strong><br \/>\nOrdinary Shareholders\u2019 Meeting for the approval of the financial statements for the year ended 31 December 2021<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 21, 2022<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the Half-Year Financial Report as at 30 June 2022<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 22, 2022<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 H1 2022<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h3>Year 2021<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>February 26, 2021<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the draft financial statements for the year ended 31 December 2020<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>March 31, 2021<\/strong> <strong>(1st meeting)<\/strong><br \/>\nOrdinary Shareholders\u2019 Meeting for the approval of the financial statements for the year ended 31 December 2020<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 22, 2021<\/strong><br \/>\nBoard of Directors\u2019 Meeting for the approval of the Half-Year Financial Report as at 30 June 2021<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 23, 2021<\/strong><br \/>\nAnalysts and Investors Conference Call \u2013 H1 2021<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3><\/h3>\n<h3>Year 2020<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>September 22, 2020<\/strong><br \/>\nBoard of Directors\u2019 approval of the Half-Year Financial Report as at 30 June 2020<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] Year 2027 &nbsp; March 11, 2027 Board of Directors\u2019 Meeting to approve the draft annual financial statements and the Consolidated Financial Statements as of 31st December 2026 &nbsp; March 12, 2027 Analysts and Investors Conference Call on the FY 2026 financial results &nbsp; April 28, 2027 (single call) Shareholders\u2019 Meeting to approve the draft annual financial statements as of December 31, 2026, and present the consolidated financial statements as of 31st December 2026 &nbsp;&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1018,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"singole-investor.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-1055","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/pages\/1055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/comments?post=1055"}],"version-history":[{"count":11,"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/pages\/1055\/revisions"}],"predecessor-version":[{"id":9202,"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/pages\/1055\/revisions\/9202"}],"up":[{"embeddable":true,"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/pages\/1018"}],"wp:attachment":[{"href":"https:\/\/www.cy4gate.com\/en\/wp-json\/wp\/v2\/media?parent=1055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}